Related Experiment Video
Updated: May 9, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Development of a dynamic quality assurance testing protocol for multisite clinical trial DCE-CT accreditation.
B Driscoll1, H Keller, D Jaffray
1Department of Radiation Physics, Princess Margaret Cancer Center, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada. brandon.driscoll@rmp.uhn.on.ca
A new quality assurance (QA) protocol for dynamic contrast enhanced-computed tomography (DCE-CT) was developed using a flow phantom. This protocol ensures reliable data comparability across institutions and scanners in clinical trials.
Area of Science:
- Medical Imaging
- Radiology
- Biomedical Engineering
Background:
- Dynamic Contrast Enhanced-Computed Tomography (DCE-CT) is increasingly used as a companion biomarker in clinical trials.
- Ensuring data quality and comparability across institutions and scanners is crucial for trial validity.
- Standardized quality assurance (QA) and control methods are needed for DCE-CT.
Purpose of the Study:
- To develop and evaluate a DCE-CT QA protocol using a dynamic flow imaging phantom.
- To address the challenge of data variability in multicenter clinical trials using DCE-CT.
- To ensure minimal deviation in results between different scanners and institutional protocols.
Main Methods:
- A validated dynamic flow phantom was used to create a DCE-CT QA protocol.
- The protocol incorporated quantitative metrics like injected and total mass error, and goodness of fit.
- Region of Interest (ROI) sensitivity analysis was performed to assess variability and optimal ROI sizes.
Main Results:
- The phantom demonstrated high robustness with <2.2% intraday variability and R2 > 0.99.
- The QA protocol detected significant deviations under suboptimal scanning parameters (low mAs/kVp).
- The protocol successfully validated DCE-CT imaging across three institutions in <90 minutes, enhancing data confidence.
Conclusions:
- A DCE-CT QA protocol was developed, effectively separating intrascanner variability from other factors.
- The protocol, combined with a dynamic flow phantom, is a valuable resource for clinical trial institutions.
- It ensures scanner performance and adherence to imaging protocols and accuracy requirements for dynamic scans.
Related Concept Videos
Clinical Trials: Overview
Preclinical Development: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinically Relevant Drug Product Specifications: Methods of Establishment
In Vitro Drug Release Testing: Overview, Development and Validation
Multiple Comparison Tests
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
